One study investigated the inhibitory effects and underlying mechanisms of APS (0, 25, 50, and 100 μg/mL) on the proliferation of human liver cancer HepG2 cells over 24 h, with or without the Akt inhibitor LY294002 (10 μmol/L). Here, AKT1 is linked to liver cancer.